Laboratory Corp. of America Holdings 

(Public, NYSE:LH)   Watch this stock   
Find more results for LH
Feb 11, 2010
Q4 2009 of America Earnings Conference Call - 9:00AM EST - Add to calendar
Feb 11, 2010
Q4 2009 of America Earnings Release - 4:30AM EST - Add to calendar
Jan 26, 2010
America at Jefferies Global Healthcare Services Conference
Jan 12, 2010
America at JPMorgan Healthcare Conference
Dec 9, 2009
America at Deutsche Bank Securities MedTools Investor Summit
Dec 1, 2009
America at Piper Jaffray Healthcare Conference - Webcast
Nov 13, 2009
America at Credit Suisse Healthcare Conference
More events from AOL Finance »    

Key stats and ratios

Q3 (Sep '09) 2008
Net profit margin 11.36% 10.31%
Operating margin 19.82% 18.71%
EBITD margin - 23.41%
Return on average assets 11.31% 10.28%
Return on average equity 26.10% 27.21%
Employees 28,000 -

Address

358 South Main Street
Burlington, NC 27215
United States - Map
+1-336-2291127 (Phone)
+1-336-5134510 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
Options - Morningstar
Research Reports - Yahoo Finance
Annual Report (PDF) - AnnualReports.com

Laboratory Corp. of America Holdings discussions

  View all discussions »

Description

Laboratory Corporation of America Holdings is an independent clinical laboratory company. The Company has a national network of 36 primary laboratories and over 1,600 patient service centers along with a network of branches and STAT laboratories (which are laboratories that have the ability to perform certain routine tests quickly and report the results to the physician immediately). Through its national network of laboratories, the Company offers a range of clinical laboratory tests that are used by the medical profession in routine testing, patient diagnosis, and in the monitoring and treatment of disease. In addition, it has developed specialty testing businesses, such as oncology testing, human immunodeficiency virus (HIV) genotyping and phenotyping, diagnostic genetics and clinical trials. In August 2009, the Company completed the acquisition of Monogram Biosciences, Inc.

Officers and directors

David P. King
Chairman of the Board, President, Chief Executive Officer
Age: 52
Bio & Compensation - Reuters
William B. Hayes
Chief Financial Officer, Executive Vice President, Treasurer
Age: 43
Bio & Compensation - Reuters
James T. Boyle Jr.
Chief Operating Officer, Executive Vice President
Age: 52
Bio & Compensation - Reuters
Andrew S. Walton
Executive Vice President - Strategic Planning and Corporate Development
Age: 42
Bio & Compensation - Reuters
Lidia L. Fonseca
Senior Vice President, Chief Information Officer
Age: 40
Bio & Compensation - Reuters
F. Samuel Eberts III
Senior Vice President, Chief Compliance Officer, Secretary, Chief Legal Officer
Age: 49
Bio & Compensation - Reuters
Mark Elliott Brecher M.D.
Senior Vice President, Chief Medical Officer
Age: 52
Bio & Compensation - Reuters
Jean-Luc Belingard
Director
Age: 60
Bio & Compensation - Reuters
Wendy E. Lane
Director
Age: 58
Bio & Compensation - Reuters
Robert E. Mittelstaedt Jr.
Director
Age: 66
Bio & Compensation - Reuters